Our previous research indicates that SIRT1 helps tumor cells cope with glucose‐deficient environments by mediating the glucolipid metabolic reprogramming, however, the impact of this process on anti‐tumor immunity remains unclear.[3] Thus, further exploration of whether SIRT1 participates in immune suppression is warranted. Here, SIRT1 is linked to neoplasm.